Modulation of HIF1-beta expression
First Claim
Patent Images
1. A compound comprising a modified oligonucleotide consisting of 12 to 30 linked nucleosides and having a nucleobase sequence comprising at least 8 contiguous nucleobases of the nucleobase sequence recited in SEQ ID NO:
- 30, wherein the nucleobase sequence of the modified oligonucleotide is at least 90% complementary to SEQ ID NO;
4 as measured over the entirety of said modified oligonucleotide, wherein said compound inhibits expression of human HIF-1 beta.
0 Assignments
0 Petitions
Accused Products
Abstract
Compounds, compositions and methods are provided for modulating the expression of HIF1-beta. The compositions comprise oligonucleotides, targeted to nucleic acid encoding HIF1-beta. Methods of using these compounds for modulation of HIF1-beta expression and for diagnosis and treatment of diseases and conditions associated with expression of HIF1-beta are provided.
-
Citations
31 Claims
-
1. A compound comprising a modified oligonucleotide consisting of 12 to 30 linked nucleosides and having a nucleobase sequence comprising at least 8 contiguous nucleobases of the nucleobase sequence recited in SEQ ID NO:
- 30, wherein the nucleobase sequence of the modified oligonucleotide is at least 90% complementary to SEQ ID NO;
4 as measured over the entirety of said modified oligonucleotide, wherein said compound inhibits expression of human HIF-1 beta. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31)
- 30, wherein the nucleobase sequence of the modified oligonucleotide is at least 90% complementary to SEQ ID NO;
Specification